喉咙痛
医学
咽炎
安慰剂
喉部
氟比洛芬
随机对照试验
麻醉
急性咽炎
内科学
物理疗法
外科
病理
替代医学
作者
Bernard Schachtel,Adrian Shephard,E. Schachtel,Mary Beth Lorton,Tim Shea,Sue Aspley
出处
期刊:Pain management
[Future Medicine]
日期:2018-01-30
卷期号:8 (2): 85-94
被引量:13
标识
DOI:10.2217/pmt-2017-0041
摘要
Patients with pharyngitis often describe various sensory, affective and evaluative pain qualities. Using an 11-word/phrase index, the Qualities of Sore Throat Index (QuaSTI), we characterized throat symptoms and evaluated changes in a randomized controlled trial (NCT01986361).Patients received a single flurbiprofen 8.75 mg (n = 101) or placebo (n = 21) lozenge and rated throat soreness at baseline and regular intervals over 3 h, and the QuaSTI at baseline, 1, 2 and 3 h post-treatment.The QuaSTI distinguished active drug from placebo and detected clinically important (≥2-point) changes over 3 h. Mean change from baseline over 3 h was significantly greater for flurbiprofen (154%) than placebo (p < 0.05).The QuaSTI is a sensitive instrument for measuring therapeutic effects in patients with pharyngitis.
科研通智能强力驱动
Strongly Powered by AbleSci AI